Patents by Inventor Fuliang Chu

Fuliang Chu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-CD79B antibodies and chimeric antigen receptors and methods of use thereof
    Patent number: 12454574
    Abstract: Provided herein are CD79b antibodies and CD79b-specific chimeric antigen receptors (CARs). Further provided herein are T cells expressing the CD79b-specific CARs and methods of treating cancer by administering the CD79b-specific CAR T cells.
    Type: Grant
    Filed: October 30, 2019
    Date of Patent: October 28, 2025
    Assignee: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Fuliang Chu, Sattva S. Neelapu, JingJing Cao, Jingwei Liu
  • ANTI-CD19 AND ANTI-CD79B CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE THEREOF
    Publication number: 20250161447
    Abstract: Aspects of the present disclosure describe dual chimeric antigen receptor (CAR) immune cells, as well as methods for making such cells and for use in treatment of cancer. Disclosed are immune cells comprising both anti-CD19 and anti-CD79b CARs and methods for use in treatment of B-cell malignancies. Also disclosed are polynucleotides encoding an anti-CD19 CAR and an anti-CD79 CAR, as well as cells comprising such polynucleotides and pharmaceutical compositions comprising such cells.
    Type: Application
    Filed: March 3, 2023
    Publication date: May 22, 2025
    Applicant: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Sattva S. NEELAPU, Xiaoyun CHENG, Jingjing CAO, Fuliang CHU
  • ANTI-CD79B ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE THEREOF
    Publication number: 20230183371
    Abstract: Provided herein are CD79b antibodies and CD79b-specific chimeric antigen receptors (CARs). Further provided herein are immune cells expressing the CD79b-specific CARs and methods of treating cancer by administering the CD79b-specific CAR immune cells.
    Type: Application
    Filed: April 30, 2021
    Publication date: June 15, 2023
    Applicant: Board of Regents, The University of Texas System
    Inventors: Fuliang CHU, Sattva S. NEELAPU, JingJing CAO, Jingwei LIU
  • ANTI-CD79B ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE THEREOF
    Publication number: 20210317209
    Abstract: Provided herein are CD79b antibodies and CD79b-specific chimeric antigen receptors (CARs). Further provided herein are T cells expressing the CD79b-specific CARs and methods of treating cancer by administering the CD79b-specific CAR T cells.
    Type: Application
    Filed: October 30, 2019
    Publication date: October 14, 2021
    Inventors: Fuliang Chu, Sattva S. Neelapu, Jingjing Cao, Jingwei Liu